Manchester Capital Management’s DexCom DXCM Stock Holding History

Manchester Capital Management’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$9.29K	Hold	148	–	–	﹤0.01%	800
2025 Q4	$9.82K	Sell	148 -32	-18%	-$2.07K	﹤0.01%	785
2025 Q3	$12.1K	Buy	180 +36	+25%	+$2.85K	﹤0.01%	843
2025 Q2	$12.6K	Sell	144 -1	-0.7%	-$78	﹤0.01%	796
2025 Q1	$9.9K	Sell	145 -9	-6%	-$734	﹤0.01%	819
2024 Q4	$12K	Buy	154 +21	+16%	+$1.55K	﹤0.01%	787
2024 Q3	$8.92K	Buy	133 +45	+51%	+$3.69K	﹤0.01%	819
2024 Q2	$9.98K	Buy	88 +9	+11%	+$1.14K	﹤0.01%	759
2024 Q1	$11K	Buy	79 +17	+27%	+$2.14K	﹤0.01%	623
2023 Q4	$7.69K	Buy	62 +54	+675%	+$5.52K	﹤0.01%	643
2023 Q3	$747	Hold	8	–	–	﹤0.01%	863
2023 Q2	$1.03K	Buy	+8	New	+$968	﹤0.01%	807
2021 Q1	–	Sell	-12	Closed	-$1K	–	677
2020 Q4	$1K	Buy	+12	New	+$1.07K	﹤0.01%	646
2015 Q1	–	Sell	-21,452	Closed	-$295K	–	627
2014 Q4	$295K	Buy	+21,452	New	+$263K	0.04%	266

Other funds holding DXCM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Manchester Capital Management's DXCM Position: Q1 2026 in Review

Manchester Capital Management held its DexCom (DXCM) position steady in Q1 2026 at 148 shares worth $9.29K. The position accounts for ﹤0.01% of the portfolio, ranked #800.

Manchester Capital Management first reported a position in DXCM in Q4 2014 and has held it in 14 quarters since. The position peaked at $295K in Q4 2014. 957 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

Manchester Capital Management held 148 shares of DexCom worth $9.29K as of Q1 2026.
Manchester Capital Management left its DexCom share count unchanged in Q1 2026.
DexCom made up ﹤0.01% of Manchester Capital Management's portfolio in Q1 2026, its #800 holding.
Manchester Capital Management first reported a position in DexCom in Q4 2014 and has held it in 14 quarters since.
Manchester Capital Management's DexCom position peaked at $295K in Q4 2014.
957 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Manchester Capital Management's 13F filing for Q1 2026, filed 11 May 2026.